Altrius Capital Management Inc Sells 41,959 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Altrius Capital Management Inc trimmed its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 18.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 182,845 shares of the company’s stock after selling 41,959 shares during the quarter. Roche makes up about 1.8% of Altrius Capital Management Inc’s investment portfolio, making the stock its 21st biggest position. Altrius Capital Management Inc’s holdings in Roche were worth $7,305,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new position in Roche in the third quarter valued at approximately $149,000. GAMMA Investing LLC lifted its holdings in Roche by 61.5% in the second quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock valued at $175,000 after buying an additional 1,919 shares during the period. Archer Investment Corp lifted its holdings in Roche by 10.6% in the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after buying an additional 652 shares during the period. Verity Asset Management Inc. acquired a new position in Roche in the third quarter valued at approximately $253,000. Finally, Waldron Private Wealth LLC acquired a new position in Roche in the second quarter valued at approximately $263,000.

Analysts Set New Price Targets

Several equities research analysts have commented on RHHBY shares. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Bank of America raised shares of Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Roche Stock Down 2.4 %

Roche stock traded down $0.88 during mid-day trading on Friday, reaching $36.14. The company’s stock had a trading volume of 1,148,126 shares, compared to its average volume of 1,155,110. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43. The business’s 50 day simple moving average is $39.04 and its 200 day simple moving average is $37.03.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.